FDA Approves Prolia, New Treatment for Osteopososis
FDA OKs Prolia for High-Risk Osteoporosis Twice-Yearly Injection Is First 'Biologic' Bone-Loss Treatment WebMD Medical News By Daniel J. DeNoon Reviewed by Laura J. Martin, MD More from WebMD Nitroglycerin...
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.